beromun
belpharma s.a. - tasonermin - sarkmein - Ónæmisörvandi, - beromun er ætlað í fullorðnir sem viðbót í aðgerð fyrir brottnám æxli svo eins og að koma í veg eða tefja aflimunar, eða í líknandi ástandi, til irresectable mjúk-vefjum sarkmein af útlimum, notuð í ásamt melfalan gegnum vægt hyperthermic einangrað-útlim gegnflæði (ilp).
pepaxti
oncopeptides ab - melphalan flufenamide hydrochloride - mergæxli - Æxlishemjandi lyf - pepaxti is indicated, in combination with dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least three prior lines of therapies, whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one anti-cd38 monoclonal antibody, and who have demonstrated disease progression on or after the last therapy. for patients with a prior autologous stem cell transplantation, the time to progression should be at least 3 years from transplantation (see section 4.
quetiapin medical valley forðatafla 300 mg
medical valley invest ab - quetiapinum fúmarat - forðatafla - 300 mg
quetiapin medical valley forðatafla 150 mg
medical valley invest ab - quetiapinum fúmarat - forðatafla - 150 mg
quetiapin medical valley forðatafla 50 mg
medical valley invest ab - quetiapinum fúmarat - forðatafla - 50 mg
quetiapin medical valley forðatafla 200 mg
medical valley invest ab - quetiapinum fúmarat - forðatafla - 200 mg
quetiapin medical valley forðatafla 400 mg
medical valley invest ab - quetiapinum fúmarat - forðatafla - 400 mg
lacosamide medical valley filmuhúðuð tafla 100 mg
medical valley invest ab - lacosamidum inn - filmuhúðuð tafla - 100 mg
lacosamide medical valley filmuhúðuð tafla 150 mg
medical valley invest ab - lacosamidum inn - filmuhúðuð tafla - 150 mg
lacosamide medical valley filmuhúðuð tafla 200 mg
medical valley invest ab - lacosamidum inn - filmuhúðuð tafla - 200 mg